romidepsin

FDA Drug Profile — ISTODAX

romidepsin is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including ISTODAX. Available dosage form: kit.

Drug details

Generic Name
romidepsin
Brand Names
ISTODAX
Application Number
NDA022393
Sponsor
Celgene Corporation
NDC Codes
2
Dosage Forms
KIT

Indications and Usage

1 INDICATIONS AND USAGE Romidepsin for injection is indicated for the treatment of cutaneous T-cell lymphoma (CTCL) in adult patients who have received at least one prior systemic therapy. Romidepsin for injection is a histone deacetylase (HDAC) inhibitor indicated for the treatment of cutaneous T-cell lymphoma (CTCL) in adult patients who have received at least one prior systemic therapy ( 1 ).

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.